SANXING(SH:601567) Zheng Quan Zhi Xing·2025-07-11 09:15Summary of Key Points Core Viewpoint The company, Ningbo SANSING Medical Electric Co., Ltd., has announced a plan to repurchase and cancel a portion of the restricted stock granted to certain incentive targets who no longer meet the eligibility criteria due to their departure from the company. This decision was made during board meetings and is in accordance with the company's stock incentive plan regulations. Group 1: Repurchase and Cancellation Details - The company will repurchase and cancel a total of 41,800 shares of restricted stock from five incentive targets who have left the company [1][15][19] - The repurchase price for the fourth phase of the restricted stock is set at 7.48 CNY per share, while for the fifth phase, it is 7.24 CNY per share [4][11] - The total amount to be paid for the repurchase is 207,694 CNY, which will be sourced from the company's own funds [18] Group 2: Implementation of Incentive Plans - The fourth phase of the restricted stock incentive plan involved granting 14,463,500 shares to 189 eligible targets, with the first grant date set for December 20, 2021 [3][10] - The fifth phase of the incentive plan granted 7,622,000 shares to 159 eligible targets, with the first grant date set for March 2, 2022 [10][11] - The company has conducted necessary internal reviews and public disclosures regarding the incentive targets and their eligibility [2][9] Group 3: Impact on Company Structure - Following the repurchase, the total number of shares will decrease from 1,411,006,571 to 1,410,964,771 [18] - The repurchase will not have a significant impact on the company's financial status or operational results [18][19] - The company will continue to fulfill its responsibilities to create value for shareholders despite the changes in stock structure [18]